Novavax Gets FDA Approval To Resume Testing Two Vaccines After Clinical Hold
Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.
BioPharma Dive2h
FDA approves new CAR-T competitor to Gilead’s Tecartus
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...
FiercePharma4h
Autolus readies its CAR-T Aucatzyl to go after heavy hitter competition following FDA nod
Watch out, Gilead and Novartis: there's a new CAR-T in town. Autolus is ready to hit the ground running after winning FDA approval for its Aucatzyl, a late entry to the heated CD19 CAR-T cell therapy ...
MassDevice5h
Momentis Surgical wins FDA nod for second-gen surgical robot
The Anovo system. [Image from Momentis] Momentis Surgical (formerly Memic) announced today that the FDA granted 510(k) ...